Compare Asuransi Dayin MitraTbk (ASDM) vs Millennium Pharmacon International Tbk. (SDPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Asuransi Dayin MitraTbk vs Millennium Pharmacon International Tbk. — how do they compare? Asuransi Dayin MitraTbk trades at Rp515 (market cap 197.76B, 200 24h volume), while Millennium Pharmacon International Tbk. trades at Rp182 (market cap 238.24B, 80.1K 24h volume). The key difference: Millennium Pharmacon International Tbk. is the larger of the two by market cap, and Millennium Pharmacon International Tbk. is more actively traded (80.1K versus 200). Which is the better fit depends on your goals.
| ASDM | SDPC | |
|---|---|---|
Market Cap | 197.76B | 238.24B |
Volume | 200 | 80.1K |
Lot | 2 | 801 |
Turnover | 103K | 14.61M |
Average Price | 515 | 182.4 |
Value | 103K | 14.61M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Asuransi Dayin MitraTbk
PT Asuransi Dayin Mitra Tbk (the Company) was incorporated based on Notarial Deed No. 4 of Didi Sudjadi, S.H., dated April 1, 1982.
Read more on ASDM →About Millennium Pharmacon International Tbk.
PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →
